Predictors and symptomatic burden of uterine fibroids among women in South-Eastern India: a cross-sectional survey analysis

Dharitri Swain, Chanchal Yadav, Jyoti Kumari, Monika Rani, Priyanka Daunrai Rongmei, Sehaj Kaur Khurana


Background: Uterine fibroid is the most common pelvic tumor in women of reproductive age and are asymptomatic in at least 50% of affected women. Various risk factors are associated with development of uterine fibroids during this reproductive age. The present study established various associated risk factors increases the prevalence of uterine fibroid among reproductive age group and clinical symptoms burden of diagnosed case.

Methods: A cross sectional study design was used to collect samples for a period of six months in an OPD basis. Purposive sampling technique was used to select the 362 sample of reproductive age group (15-45 years) women in a tertiary care hospital, Southeastern India. Women diagnosed with uterine fibroid by ultrasonography were included as cases. Symptomatic features and associated risk factors of UF were collected through structure interview schedule.

Results: Point prevalence of uterine fibroid among women in reproductive age group during the period of six months was 20%. Majority of them were in the age group of 30-39 years. Demographic factor such as overweight and obesity and consume dairy products daily has increased the prevalence of UF, whereas use of oral contraceptive pills and normal BMI had inverse relationship with UF risk. Most of the cases reported of having menstrual disturbances like heavy bleeding, passes blood clots during menstruation, prolonged period, urinary symptoms and pressure symptoms were considered independent predicting factors for the occurrence of uterine fibroid.

Conclusions: Uterine fibroid is more prevalent among women of reproductive age causing various bleeding and renal symptoms that can have negative impact on quality of women’s life.


Determinants, Menstrual irregularities, Reproductive age group, Uterine fibroid

Full Text:



Graves WP. Uterine myomata (fibroids). In: Curtis AH, ed. Obstetrics and Gynecology, 2nd vol. WB Saunders: Philadelphia. 1933:745-783.

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100-7.

Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini S, Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population based cohort study. Hum Reprod. 2004;19:2350-5.

Ekine AA, Lawani LO, Iyoke CA, Jeremiah I, Ibrahim IA. Review of the clinical presentation of uterine fibroid and the effect of therapeutic intervention on fertility. Am J Clin Med Res. 2015;3:9-13.

Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, et al. Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African- American women: a prospective study. Am J Epidemiol. 2004;159(2):113-23.

Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995;172(1 Pt 1):14-8.

Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol. 1996;14(3):269-82.

Moravek MB, Bulun SE. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Current Opinion Obstet Gynecol. 2015;27(4):276.

Naik S, Nathan LT. Indian prevalence rate, fibroid uterus. National Institute of Health Science. 2006:275-8.

Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women's Health. 2012;12(1):6.

Fuldeore MJ, Soliman AM. Patient reported prevalence and symptomatic burden of uterine fibroids among women in the united states: finding from a cross sectional survey. Int J Womens Health. 2012; 9:403-11.

Ukwenya V, Maduemezia N, Afolayan O, Alese O, Thomas W. Prevalence of uterine fibroid in a South-Western Nigerian population: A sonographic study. J Exp Clin Anatomy. 2015;14(1):24-9.

Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand. 2000;79:202-7.

Bizjak T, Bečić A, But I. Prevalence and Risk Factors of Uterine Fibroids in North-East Slovenia. Gynecol Obstet. 2016;6(01):350.

Munusamy MM, Sheelaa WG, Lakshmi VP. Clinical presentation and prevalence of uterine fibroids: a 3-year study in 3-decade rural South Indian women. Int J Reprod Contracept Obstet Gynecol. 2017;6(12):5596-601.

Terry KL, De Vivo I, Hankinson SE, Missmer SA. Reproductive characteristics and risk of uterine leiomyomata. Fertil Steril. 2010;94:2703-7.

Blake RE. Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc. 2007;99:1170-84.

Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111:1037-54.

Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. BJOG. 1996;103:909-14.

Flake GP, Andersen J, Dixon D. Etiology and pathophysiology of uterine leiomyomas; a review. Environ Health Perspect. 2003;111:1037-54.

Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:571-88.

Commandeur AE, Styer AK, Teixeira JM. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update. 2015;21:593-615.

Stewart EA, Cookson CL, Gandolfo RA, Schulze‐Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-12.

Abbas HY, Awad IA, Alharbi E, Alaameri H, Althubaiti S, Ashkar L. Prevalence and incidence of uterine fibroid at King Abdulaziz University Hospital Saudi Arabia. Clinical Med Diagnos. 2016;6(3):45-8.

Payson M, Leppert P, Segars J. Epidemiology of Myomas. Obstet Gynecol Clin North Am. 2006;33:1-11.

Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J. 1986;293:359-62.

Hodge JC, Morton CC. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet. 2007;16(R1):R7-R13.

Khyade, RL. A study of menstrual disturbance in cases of fibroid uterus. Int J Reprod Contracept Obstet Gynecol.2017;6(6):2494-7.

Bachmann GA, Bahouth LA, Amalraj P, Mhamunkar V, Hoes K, Ananth CV. Uterine fibroids: Correlations of anemia and pain to fibroid location and uterine weight. J Reprod Med. 2011;56(11-12):463-6.

Brito LG, Panobianco MS, Sabino-de-Freitas MM, de Freitas Barbosa H, de Azevedo GD, Brito LM, et al. Uterine leiomyoma: understanding the impact of symptoms on womens’ lives. Reprod Health. 2014;11(1):10.

He Y, Zeng Q, Dong SY, Qin LQ, Li GW, Wang PY. Associations between uterine fibroids and lifestyles including diet, physical activity and stress: a case-control study in China. Asia Pacific J Clin Nutr. 2013;22(1):109-17.